Abstract:Objective To investigate the clinical features and laboratory results in a patient with late onset autosomal recessive spastic ataxia of Charlevoix-Saguenay ( ARSACS ) carrying novel SACS ( spastic ataxia of Charlevoix-Saguenay ) gene heterozygous mutations .Methods A 26-year-old Chinese man developed since the age of 13 a progressive weakness and stiffness of his bilateral lower limbs and gait unsteadiness.He had pyramidal tract sign in his bilateral lower limbs , cerebellar ataxia and sensory-motor polyneuropathy , with hyperelastica and swan neck-like deformities of the fingers , pes cavus and hammer toes.Funduscopy and optical coherence tomography , brain and cervical MRI , conduction velocity of peripheral nerve , motor evoked potentials , visual and brainstem auditory evoked potentials , ultrasound of peripheral nerve , hips and legs MRI , electronystagmography , and targeted capture and next generation sequencing were performed .Results Funduscopy and optical coherence tomography revealed thickening of the retinal nerve fiber layer with unclear margined optic disc .MRI revealed symmetrical linear hypointensity lesions in the pons on T 2 and T2 FLAIR weighted images , thickened bilateral cerebellar peduncles , and flattened and atrophied cervical and upper thoracic spinal cord .Nerve conduction studies showed sensory nerve action potentials were absent in four limbs , motor conduction velocity was slowed , amplitude of muscle response was significantly decreased in lower-limb nerves ( decreased by 80% -100%) but normal in upper-limb nerves.Central motor conduction time of motor evoked potential was prolonged .Targeted capture and next generation sequencing revealed novel SACS compound heterozygous mutations , c.12637 _12638delGA (p.Glu4213ArgFs*3) and c.11274_11276delAAC (p.Ile3758_Thr3759delinsMet) derived from each parent respectively , which were confirmed by Sanger sequencing analyses . Conclusions Recognizing ARSACS triad and its characteristics on fundus and brain MRI is helpful for correct diagnosis . Our findings expand the clinical and genetic spectrum of ARSACS .

Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS

Spinocerebellar Ataxia in Brazil: A Comprehensive Genotype – Phenotype Analysis

Olfactory Impairment in Familial Ataxias.

To Investigate Olfactory Impairment in Cerebellar Ataxia

Novel Spastic Ataxia of Charlevoix-Saguenay Gene Compound Heterozygous Mutations in Late Onset Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay

Clinical and genetic variability among Bulgarian patients with autosomal recessive spastic ataxia of Charlevoix-Saguenay

Clinical and Genetic Characterization of a Cohort of Brazilian Patients With Congenital Ataxia

Subcellular, biochemical and biophysical alterations in two glial cell models of ARSACS

ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia

Clinical and epidemiological profiles from a case series of 26 Brazilian CADASIL patients

Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)☆

Longitudinal Imaging Biomarkers Correlate with Progressive Motor Deficit in the Mouse Model of Charlevoix‐Saguenay Ataxia

Neuropathy in ARSACS is demyelinating but without typical nerve enlargement in nerve ultrasound

MRI‐ARSACS: An Imaging Index for Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay (ARSACS) Identification Based on the Multicenter PROSPAX Study

A Novel SACS Variant Identified in a Chinese Patient: Case Report and Review of the Literature

Clinicogenetic characterization of cerebrotendinous xanthomatosis in Brazil

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Complicated Paroxysmal Kinesigenic Dyskinesia Associated with SACS Mutations.

Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)

Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia

Volumetric MRI Changes in Spinocerebellar Ataxia (SCA3 and SCA10) Patients